RHG Real Hotel Grp

RNS Number:3247U
James Reed & Partners PLC
17 November 2005


                      Reed Health Group plc - Offer Update

  Not for release, publication or distribution in or into the United States of
                      America, Canada, Australia or Japan.

                             Increased Cash Offers

                     by Altium Capital Limited on behalf of

                           James Reed & Partners plc

                                      for

                     Reed Health Group plc ("Reed Health")

James Reed & Partners plc ("JRP") announces that it has today acquired
10,849,816 Ordinary Shares in Reed Health at above the cash offer price of 55p
per share contained in the offer document dated 10 November 2005 (the "Offer
Document"). The price at which it acquired these shares is 57.5p per share.

Since the offer period began, on 8 November 2005, JRP has purchased a total of
15,509,013 Ordinary Shares, representing approximately 26.0 per cent. of the
issued share capital of Reed Health. In addition, JRP has received irrevocable
undertakings to accept its Offers in respect of 34,919,248 shares in Reed
Health, representing approximately 58.5 per cent. of the issued share capital 
of Reed Health. Therefore, JRP either owns, or holds irrevocable undertakings to
accept its Offers over a total of 50,428,261 shares in Reed Health,
representing, in aggregate, approximately 84.5 per cent. of the existing issued
share capital of Reed Health.

In accordance with Rule 6.2(b) of the Code, JRP confirms that it will shortly
increase its cash offer to 57.5p per share (the "Increased Offer").

A full announcement will be made as soon as practicable.

PRESS ENQUIRIES for James Reed & Partners plc:

Smithfield

Reg Hoare / Katie Hunt 020 7360 4900

This announcement and the Increased Offer should be read in conjunction with,
and is subject to, the full terms and conditions set out in the Offer Document
and the Forms of Acceptance.

Terms used in this announcement shall have the same meaning as those in the 
Offer Document.

The directors of James Reed & Partners (the "Directors") accept responsibility 
for the information contained in this announcement. To the best of the knowledge
and belief of the Directors (who have taken all reasonable care to ensure 
that such is the case), the information contained herein is in accordance with 
the facts and does not omit anything likely to affect the import of such 
information.

The release, publication or distribution of this announcement in certain
jurisdictions may be restricted by law and therefore persons in any such
jurisdictions into which this announcement is released, published or distributed
should inform themselves about and observe any applicable requirements.

The Offers (including the Loan Note Alternative) will not be made, directly or
indirectly, in, into or from the United States, or by use of the United States
mails, or by any means or instrumentality (including, without limitation,
facsimile transmission, telex, telephone or e-mail) of United States interstate
or foreign commerce, or any facility of a national securities exchange of the
United States, Canada, Australia or Japan. Accordingly, this announcement,
copies of this announcement and any related documents are not being and must not
be mailed or otherwise distributed or sent in, into or from the United States,
Canada, Australia or Japan and persons receiving this document and any related
documents (including custodians, nominees and trustees) must not mail or
otherwise forward, distribute or send them in, into or from the United States,
Canada, Australia or Japan. All Reed Health Shareholders (including nominees,
trustees or custodians) who would, or otherwise intend to forward this
announcement, should inform themselves about and observe any applicable
requirement.

Altium Capital Limited, which is authorised and regulated in the United Kingdom
by the Financial Services Authority, is acting exclusively for James Reed &
Partners as financial adviser within the meaning of the Rules of the Financial
Services Authority and for no one else in connection with the Offers. Altium
Capital Limited is not advising any other person or treating any other person as
its client in relation thereto and will not be responsible to anyone other than
James Reed & Partners for providing the protections afforded to clients of
Altium Capital Limited, or for giving advice to any other person in relation to
the Offers, the contents of this announcement or any other matter referred to
herein.

END




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
OUPBRBRTMMBBBJA

Reed Health (LSE:RHG)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024

Reed Health (LSE:RHG)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024